Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Louie H. Yu"'
Autor:
Entezam Sahovic, Cathy Zhao, Scott R. Solomon, Louie H. Yu, Elizabeth Armstrong, Kazunobu Kato, Voravit Ratanatharathorn, Darrell White, Juan J. Toro, Paul J. Shaughnessy, Cesar O. Freytes, Tulio E. Rodriguez, Agnes Elekes, Shiva Patil, Guido Tricot, Donna E. Reece, Angela Smith, Rosa F. Yeh, Edward A. Stadtmauer, Gorgun Akpek
Publikováno v:
Biology of Blood and Marrow Transplantation. 20:1949-1957
Patients with multiple myeloma (MM) who relapse after autologous transplantation have limited therapeutic options. We conducted a prospective, multicenter, phase IIa study to investigate the safety and efficacy of i.v. busulfan (Bu) in combination wi
Autor:
Ira Braunschweig, Elizabeth Armstrong, Kazunobu Kato, Thomas C. Shea, Agnes Elekes, William P. Vaughan, Luciano J. Costa, Damiano Rondelli, Michael Craig, Rosa F. Yeh, Mitchell E. Horwitz, Cesar O. Freytes, Edmund K. Waller, Louie H. Yu, Stephen Lim, Joseph W. Fay, Tsiporah B. Shore, James R. Mason, Yiping Sun, Michael Lill, Shiva Patil, Shin Mineishi
Publikováno v:
Biology of Blood and Marrow Transplantation. 18(2)
Autor:
Kazunobu Kato, Juan J. Toro, Tulio E. Rodriguez, Rosa F. Yeh, Agnes Elekes, Paul J. Shaughnessy, Edward A. Stadtmauer, Darrell White, Elizabeth Armstrong, Scott R. Solomon, Cesar O. Freytes, Yiping Sun, Guido Tricot, Donna E. Reece, Angela Smith, Gorgun Akpek, Louie H. Yu, Entezam Sahovic, Voravit Ratanatharathorn, Shiva Patil
Publikováno v:
Biology of Blood and Marrow Transplantation. 19:S186-S187
s / Biol Blood Marrow Transplant 19 (2013) S178eS193 S186 may be warranted to discern if DM pts may benefit from different methods of mobilization or if long term transplant outcomes are impacted.
Autor:
Luciano J. Costa, Elizabeth Armstrong, Cesar O. Freytes, Edmund K. Waller, Ian W. Flinn, Robert K. Stuart, Tsiporah B. Shore, Michael Craig, Rosa F. Yeh, Shiva Patil, Thomas C. Shea, Agnes Elekes, Isabelle Bence-Bruckler, Stephen Lim, Michael Lill, Angela Smith, Yiping Sun, Tulio E. Rodriguez, Andrew M. Yeager, Kazunobu Kato, Terrance Comeau, Michael A. Pulsipher, William P. Vaughan, Pierre Laneuville, Andy I. Chen, Philip J. Bierman, Louie H. Yu
Publikováno v:
Biology of Blood and Marrow Transplantation. 19:S132
Autor:
Juan J. Toro, Elizabeth Armstrong, Guido Tricot, Louie H. Yu, Entezam Sahovic, Kazunobu Kato, Agnes Elekes, Donna E. Reece, Angela Smith, Cesar O. Freytes, Rosa F. Yeh, Scott R. Solomon, Shiva Patil, Gorgun Akpek, Yiping Sun, Tulio E. Rodriguez, Darrell White, Edward A. Stadtmauer, Paul J. Shaughnessy, Voravit Ratanatharathorn
Publikováno v:
Blood. 120:3080-3080
Abstract 3080 Background: Salvage therapeutic options are limited for multiple myeloma (MM) patients who relapse after autologous hematopoietic stem cell transplantation (ASCT). A second ASCT using a different conditioning regimen may provide long-te
Autor:
Ian W. Flinn, Cesar O. Freytes, Edmund K. Waller, Terrance Comeau, Luciano J. Costa, Thomas C. Shea, Agnes Elekes, Kazunobu Kato, Michael A. Pulsipher, Philip J. Bierman, Stephen Lim, Michael Lill, Louie H. Yu, Isabelle Bence-Bruckler, Shiva Patil, Yiping Sun, Tsiporah B. Shore, Michael Craig, Rosa F. Yeh, Tulio E. Rodriguez, Pierre Laneuville, Angela Smith, Robert K. Stuart, Elizabeth Armstrong, William P. Vaughan, Andy I. Chen
Publikováno v:
Blood. 120:813-813
Abstract 813 Background: Published reports indicate that oral or intravenous (IV) busulfan in combination with cyclophosphamide and VP-16 (BuCyVP-16) is an effective conditioning regimen with acceptable safety profile for lymphoma patients prior to a
Autor:
Agnes Elekes, Shiva Patil, Guido Tricot, Tulio E. Rodriguez, Louie H. Yu, Donna E. Reece, Kazunobu Kato, Cesar O. Freytes, Scott R. Solomon, Voravit Ratanatharathorn, Darrell White, Yiping Sun, Edward A. Stadtmauer, Elizabeth Armstrong, Juan J. Toro, Rosa F. Yeh, Entezam Sahovic, Paul J. Shaughnessy, Gorgun Akpek
Publikováno v:
Blood. 118:4509-4509
Abstract 4509 BACKGROUND: Once multiple myeloma (MM) relapses after a first autologous hematopoietic stem cell transplantation (HSCT), long-term disease control is challenging because of limited therapeutic options. A second autologous HSCT is one of